Natália Araújo is envolved in research activities at Unidade Local de Saúde de Gaia e Espinho, where she is part of the team of the Early Phase Clinical Trials Unit - EPCTU. She is also an integrated member of EPIUnit-ISPUP (Epidemiology Research Unit of the Institute of Public Health of the University of Porto and of ITR-ISPUP (Laboratory for Integrative and Translational Research in Population Health), where she has been working in the field of Cognitive Decline in survivors of breast and prostate cancers and of COVID-19. She holds a Ph.D. in Public Health (Faculty of Medicine, University of Porto, 2017-2021; grant from the Foundation for Science and Technology, Ministry of Science, Technology and Education) and training in Pharmaceutical Sciences (Faculty of Pharmacy, University of Porto, 1995 -2001). She was a research fellow for a year and a half (2002-2003) at the Biochemistry Lab. of the Faculty of Pharmacy of the University of Porto (study of the immunological activity of Leishmania infantum proteins and polyamine derivatives; laboratory techniques: ELISA, production, isolation and quantification of Leishmania infantum proteins, flow cytometry, in vitro culture of macrophage cell lines and Leishmania infantum amastigotes and promastigotes). She worked as a pharmacist for ten years (2003-2013) in Community Pharmacies in Porto. Since 2016, she has been working full-time on longitudinal studies evaluating cognitive decline in patients with breast and prostate cancer. She was deeply involved in the design, planning and writing of four proposals of prospective studies on cognitive decline for grant applications (competitive calls 2017, 2020, 2021), of which two were approved (funded by the European Regional Development Fund and Foundation for Science and Technology). She is the author/co-author of 27 full-length scientific articles published in international peer-reviewed indexed journals (8 papers as first author, two articles as senior author). She has experience in activities related to the implementation and follow-up of prospective cohort studies (sample size: 600 participants) and in quantitative data analysis. She also has teaching experience in Pharmacoepidemiology, Epidemiology, and Medicines and Health. She co-supervised a Master dissertation, she was the supervisor of a Master dissertation, and she is co-supervisor of three PhD students in Public Health.